UK markets close in 2 hours 1 minute
  • FTSE 100

    +36.65 (+0.52%)
  • FTSE 250

    +191.96 (+0.85%)
  • AIM

    +5.71 (+0.46%)

    -0.0014 (-0.12%)

    +0.0031 (+0.22%)

    -226.38 (-0.55%)
  • CMC Crypto 200

    +19.95 (+1.36%)
  • S&P 500

    +34.03 (+0.82%)
  • DOW

    +318.19 (+0.93%)

    -0.31 (-0.48%)

    +18.70 (+1.03%)
  • NIKKEI 225

    +26.45 (+0.09%)

    -26.81 (-0.09%)
  • DAX

    +153.28 (+1.01%)
  • CAC 40

    -0.38 (-0.01%)

Real-World Evidence (RWE) Solutions Market Report 2020-2030

·4-min read

Forecasts by Component (Data Sets, Services), Datasets (Clinical Settings Data, Claims Data, Pharmacy Data, Patient-Powered Data, Others), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurology, Immunology, Other Therapeutic Areas), End-users (Healthcare Payers, Healthcare Providers, Pharmaceutical & Medical Device Companies, Other End-users), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), PLUS COVID-19 Recovery Scenarios and Profiles of Leading Real-World Evidence Solutions Companies.

New York, April 13, 2021 (GLOBE NEWSWIRE) -- announces the release of the report "Real-World Evidence (RWE) Solutions Market Report 2020-2030" -

Real-world evidence (RWE) will be essential in beating COVID-19. Patients, vaccine recipients, healthcare workers – Real-World data needs to be gathered to guide treatment decisions, risk-assessments, and standards of care and practice.

RWE is essential NOW. You must read this report – today. RWE offers you a treatment roadmap – read this report to discover how.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report immediately.

• Increasing us of big Data in Healthcare
• Growing use of smart wearables, sensors, and devices which collect real world data
• Usage of RWE in biopharma
• RWE can enhance clinical trials as seen in COVID-19 work

• Patient privacy issue
• Lack of adequate financing and high capital investment

• Increasing use of patient centric programs
• Long term outlook for chronic disease management

This report tells you how to stay ahead
• Unique 270+ page report – delivers 350+ tables and charts/graphs.
• Find out the most lucrative areas in the industry and the future market prospects.
• Delivers forecasted sales at overall world market, regional and country level.
• Gives you financial results, trends, opportunities, and revenue predictions.
• Shows you the opportunities in this growing Real-World Evidence Market and how to exploit them.

Forecasts to 2030 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT Analysis, product profiles and commercial developments.

UNIQUE COVID-19 VARIATIONS – only available in this this report are dedicated analysis of 4 different rebound scenarios of how the market will develop – no matter how COVID-19 effects the economy.

Discover sales predictions for the world market and submarkets

By Component
• Data Sets
• Services

By Datasets
• Clinical Settings Data
• Claims Data
• Pharmacy Data
• Patient-Powered Data
• Others

By Therapeutic Area
• Oncology
• Cardiovascular Diseases
• Neurology
• Immunology
• Other Therapeutic Areas

By End-Users
• Healthcare Payers
• Healthcare Providers
• Pharmaceutical & Medical Device Companies
• Other End-Users

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 4 regional and 10 leading national markets:

By Region

• North America
• U.S.
• Canada

• Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe

• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific

• RoW

Leading companies and the potential for market growth
Overall world revenue for Real-World Evidence Market will surpass $xx million in 2020, our work calculates. We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Real-World Evidence Market report helps you
In summary, our 270+ page report provides you with the following knowledge:

• Revenue forecasts to 2030 for Real-World Evidence Market, with forecasts for xx, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues

• Revenue forecasts to 2030 for 5 regional and xx key national markets – See forecasts for the Real-World Evidence market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Brazil, Germany, France, UK, Italy, Spain, China, India, and Japan, among other prominent economies.

• Prospects for established firms and those seeking to enter the market– including company profiles for 13 of the major companies involved in the Real-World Evidence Market. Some of the company’s profiled in this report include:
• Iqvia
• Pharmaceutical Product Development
• Optum (A Subsidiary of United Health Group, Inc.)
• PerkinElmer
• Icon PLC
• Oracle
• Cognizant
• Syneos Health
• Anthem
• Clinigen
• Covance Inc.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. This study is for everybody needing commercial analyses for the Real-World Evidence Market and leading companies. You will find data, trends and predictions.
Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


CONTACT: Clare: US: (339)-368-6001 Intl: +1 339-368-6001